Intelligent Bio Solutions (INBS) Common Equity (2021 - 2024)
Historic Common Equity for Intelligent Bio Solutions (INBS) over the last 4 years, with Q1 2024 value amounting to $11.1 million.
- Intelligent Bio Solutions' Common Equity rose 8473.52% to $11.1 million in Q1 2024 from the same period last year, while for Mar 2024 it was $11.1 million, marking a year-over-year increase of 8473.52%. This contributed to the annual value of $3.8 million for FY2023, which is 4265.62% down from last year.
- Per Intelligent Bio Solutions' latest filing, its Common Equity stood at $11.1 million for Q1 2024, which was up 8473.52% from $3.3 million recorded in Q4 2023.
- In the past 5 years, Intelligent Bio Solutions' Common Equity registered a high of $15.9 million during Q1 2021, and its lowest value of $1.4 million during Q3 2023.
- Moreover, its 4-year median value for Common Equity was $8.8 million (2022), whereas its average is $8.7 million.
- In the last 5 years, Intelligent Bio Solutions' Common Equity plummeted by 6803.87% in 2023 and then skyrocketed by 8473.52% in 2024.
- Over the past 4 years, Intelligent Bio Solutions' Common Equity (Quarter) stood at $13.6 million in 2021, then decreased by 24.3% to $10.3 million in 2022, then crashed by 68.04% to $3.3 million in 2023, then surged by 239.4% to $11.1 million in 2024.
- Its last three reported values are $11.1 million in Q1 2024, $3.3 million for Q4 2023, and $1.4 million during Q3 2023.